Eledon Pharmaceuticals (ELDN) Institutional Ownership → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free ELDN Stock Alerts $2.06 +0.04 (+1.98%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Eledon Pharmaceuticals (NASDAQ:ELDN)CurrentInstitutional OwnershipPercentage56.77%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$3.43MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$68.12K Get ELDN Insider Trade Alerts Want to know when executives and insiders are buying or selling Eledon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELDN Institutional Buying and Selling by Quarter Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Eledon Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC2,189,000$3.94M0.1%+20.0%9.045% 11/15/2023Armistice Capital LLC1,824,000$2.50M0.0%-1.0%7.538% 10/19/2023Jmac Enterprises LLC58,041$80K0.0%-27.5%0.246% 8/15/2023BVF Inc. IL4,326,710$5.93M0.2%+86.0%18.372% 8/11/2023SVB Financial Group18,025$25K0.0%-33.1%0.080% 7/20/2023Jmac Enterprises LLC80,041$110K0.0%+46.8%0.356% Get the Latest News and Ratings for ELDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023CM Management LLC234,800$535K0.6%-4.2%1.706% 11/14/2022Cormorant Asset Management LP1,223,500$3.38M0.2%-6.3%8.894% 11/14/2022Point72 Asset Management L.P.375,000$1.04M0.0%-12.5%2.726% 11/14/2022Boothbay Fund Management LLC22,050$61K0.0%-36.3%0.160% 11/4/2022CM Management LLC245,000$676K0.8%+8.9%1.781% 8/16/2022Woodline Partners LP516,675$1.26M0.0%-23.2%3.755% 5/9/2022CM Management LLC225,000$887K0.7%+95.7%1.636% 4/25/2022Bailard Inc.27,600$109K0.0%N/A0.193% 2/14/2022Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016% 2/11/2022Ensign Peak Advisors Inc77,100$340K0.0%+966.7%0.539% 2/7/2022Ameritas Advisory Services LLC24,219$107K0.0%N/A0.169% 2/2/2022CM Management LLC115,000$507K0.4%+53.3%0.804% 11/16/2021Two Sigma Advisers LP115,900$716K0.0%+48.0%0.810% 11/16/2021Two Sigma Investments LP115,324$713K0.0%+100.5%0.806% 11/16/2021BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530% 11/15/2021Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464% 11/15/2021Eversept Partners LP114,008$705K0.1%N/A0.797% 11/15/2021Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051% 11/10/2021Mercer Global Advisors Inc. ADV16,726$103K0.0%N/A0.117% 8/18/2021Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446% 8/17/2021Woodline Partners LP857,445$6.78M0.1%-3.8%5.993% 8/17/2021Boothbay Fund Management LLC40,052$317K0.0%+39.6%0.280% 8/16/2021Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319% 8/16/2021Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948% 8/16/2021State Street Corp32,935$261K0.0%N/A0.230% 8/13/2021Renaissance Technologies LLC21,107$167K0.0%-22.0%0.148% 8/13/2021Northern Trust Corp32,116$254K0.0%+106.8%0.224% 8/13/2021Geode Capital Management LLC124,614$985K0.0%+25.7%0.871% 8/13/2021Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466% 5/19/2021Logos Global Management LP224,071$2.40M0.2%N/A1.566% 5/18/2021BVF Inc. IL1,113,435$11.91M0.4%N/A7.782% 5/18/2021Millennium Management LLC14,588$156K0.0%N/A0.102% 5/18/2021Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874% 5/18/2021Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894% The Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.5/18/2021Citadel Advisors LLC25,062$268K0.0%N/A0.175% 5/17/2021Woodline Partners LP891,055$9.53M0.2%N/A6.228% 5/17/2021EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798% 5/17/2021Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495% 5/17/2021Ikarian Capital LLC250,000$2.68M0.1%N/A1.747% 5/13/2021Renaissance Technologies LLC27,051$289K0.0%N/A0.189% 5/12/2021Northern Trust Corp15,528$166K0.0%N/A0.109% 5/12/2021Geode Capital Management LLC99,123$1.06M0.0%N/A0.693% 5/12/2021CM Management LLC75,000$803K0.6%N/A0.524% 5/7/2021BlackRock Inc.12,282$131K0.0%N/A0.086% 4/21/2021Ingalls & Snyder LLC51,149$547K0.0%N/A0.358% (Data available from 1/1/2016 forward) ELDN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELDN shares? During the previous two years, 9 institutional investors and hedge funds held shares of Eledon Pharmaceuticals. The most heavily invested institutionals were BVF Inc. IL ($5.93M), Armistice Capital LLC ($3.94M), Cormorant Asset Management LP ($3.38M), Woodline Partners LP ($1.26M), Point72 Asset Management L.P. ($1.04M), CM Management LLC ($535K), and Jmac Enterprises LLC ($80K).Learn more on ELDN's institutional investors. What percentage of Eledon Pharmaceuticals stock is owned by institutional investors? 56.77% of Eledon Pharmaceuticals stock is owned by institutional investors. Learn more on ELDN's institutional investor holdings. Which institutional investors have been buying Eledon Pharmaceuticals stock? The following institutional investors have purchased Eledon Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($2M), Armistice Capital LLC ($365K), CM Management LLC ($130K), and Jmac Enterprises LLC ($25.50K). How much institutional buying is happening at Eledon Pharmaceuticals? Institutional investors have bought a total of 2,520,503 shares in the last 24 months. This purchase volume represents approximately $3.92M in transactions. Which Eledon Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Eledon Pharmaceuticals stock in the last 24 months: Woodline Partners LP ($156.46K), Cormorant Asset Management LP ($81.60K), Point72 Asset Management L.P. ($53.36K), Jmac Enterprises LLC ($22K), Armistice Capital LLC ($18.80K), Boothbay Fund Management LLC ($12.58K), and CM Management LLC ($10.20K). How much institutional selling is happening at Eledon Pharmaceuticals? Institutional investors have sold a total of 363,918 shares in the last 24 months. This volume of shares sold represents approximately $880.34K in transactions. Related Companies: CLNN Institutional Ownership MRKR Institutional Ownership UNCY Institutional Ownership CARA Institutional Ownership NRXP Institutional Ownership PMN Institutional Ownership OCUP Institutional Ownership BCTX Institutional Ownership RMTI Institutional Ownership BOLT Institutional Ownership This page (NASDAQ:ELDN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsBiden out June 13; Kamala won’t replace him?Paradigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.